Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.

Anubodh S VarshneyMiloni ShahSreekanth VemulapalliAndrzej KosinskiAnkeet S BhattAlexander T SandhuSameer HirjiErsilia M DeFilippisPinak B ShahMona FiuzatPatrick T O'GaraDeepak L BhattTsuyoshi KanekoMichael M GivertzMuthiah Vaduganathan

Published in: European heart journal (2023)

Under one-fifth of patients with LVEF <50% who underwent MTEER for FMR in this US nationwide registry were prescribed comprehensive GDMT, with substantial variation across sites. Compared with no/single therapy, triple and double therapy prior to MTEER were independently associated with reduced risk of mortality or HFH one year after intervention.

Keyphrases

heart failure
mitral valve
randomized controlled trial
left ventricular
stem cells
type diabetes
risk factors
atrial fibrillation
aortic stenosis
cell therapy
transcatheter aortic valve replacement